Abstract
Rupatadine is a new poly-functional agent (selective histamine H 1-receptor and PAF-receptor antagonist with additional anti-inflammatory potency) for the management of patients with allergic rhinitis and chronic urticaria. It has a rapid onset of action, and its long-lasting effect permits once-daily dosing. It has been shown that rupatadine is effective, well-tolerated and safe in relieving symptoms in patients with seasonal and perennial/ intermittent and persistent allergic rhinitis and chronic urticaria.
Reference56 articles.
1. Адо А.Д. Общая аллергология. М., «Медицина». 1978, 463 с.
2. Гущин И.С. Аллергическое воспаление и его фармакологический контроль. М., «Фармарус Принт». 1998, 252 с.
3. Ferstl R., Akdis C.A., O’Mahony L. Histamine regulation of innate and adaptive immunity. Front. Biosci. 2012, v. 17, p. 40-53.
4. Гущин И.С. Полифункциональная противоаллергическая активность антигистаминного препарата рупатадина. Рос. Аллергол. Журн. 2012, № 4, с. 3-12.
5. Curtin M.L. Current status of platelet-activating factor antagonists. Exp. Opin. Ther. Patents. 1998, v. 8, p. 703-711.